🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Follicular Lymphoma

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma NCT06536049Phase 1, Phase 23 sites📍 Minneapolis📍 Columbus📍 Richmond Yazeed Sawalha · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Epcoritamab Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Lenalidomide combined with G-CHOP (LO CHOP) PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital STimulation to Activate RespIration NCT06832306NA7 sites📍 La Jolla📍 Shreveport📍 Winston-Salem Lungpacer Medical Inc. · Tests: Phrenic Nerve Stimulation Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) NCT07083154Phase 38 sites📍 Changsha📍 Changzhou📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Mazdutide, Placebo Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T NCT06784726Phase 21 site📍 Seattle University of Washington · Tests: Odronextamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Ther… Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL NCT06806033Phase 253 sites📍 Anchorage📍 Clovis📍 Fullerton Hoffmann-La Roche · Tests: Obinutuzumab, Glofitamab, Gemcitabine, Oxaliplatin A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL NCT05899621n/a1 site📍 Shanghai Ruijin Hospital · Tests: Obinutuzumab, Lenalidomide, Bendamustine, Cyclophosphamide, Doxorubicin Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma NCT07299149Phase 22 sites📍 Tianjin📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Induction Therapy: Zanubrutinib, obinutuzumab, lenalidomide, Maintenance therapy: Zanubrutinib, lenalidomide Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype NCT06522737Phase 344 sites📍 Ghent📍 Leuven📍 Prague SecuraBio · Tests: Duvelisib, Gemcitabine, Bendamustine Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital NCT06560372NA1 site📍 Fort-de-France University Hospital Center of Martinique · Tests: Additional realization of a brain perfusion scan sequence which would allow the radiological diagnosis of CV Epco, Zanu, Ritux for R/R FL or MZL NCT06563596Phase 23 sites📍 Boston📍 New York📍 Columbus Reid Merryman, MD · Tests: Zanubrutinib, Rituximab, Epcoritamab Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy NCT05255354n/a1 site📍 Palo Alto Adaptive Biotechnologies · Tests: ClonoSEQ Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries NCT05849857Phase 23 sites📍 Helsinki📍 Oslo📍 Trondheim Oslo University Hospital · Tests: Mosunetuzumab Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients NCT04844866Phase 251 sites📍 Graz📍 Innsbruck📍 Linz Miltenyi Biomedicine GmbH · Tests: MB-CART2019.1, Standard of Care Odronextamab in Low Tumor Volume Advanced FL NCT07128641Phase 21 site📍 Boston Gottfried von Keudell, MD PhD · Tests: Odronextamab CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma NCT06209619Phase 11 site📍 Columbus Nathan Denlinger · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Golcadomide, Positron Emission Tomography Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites📍 Los Angeles📍 Washington D.C.📍 Baton Rouge Montefiore Medical Center · Tests: Standard of Care Referral, Low Threshold Buprenorphine Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites📍 Bundang Gu📍 Seongnam-si📍 Gyeonggi-do Novartis Pharmaceuticals · Tests: Tisagenlecleucel Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma NCT07731789Phase 21 site📍 Seattle University of Washington · Tests: Rituximab, Tafasitamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) NCT07634471Phase 2, Phase 335 sites📍 Duarte📍 Lexington📍 Hackensack Merck Sharp & Dohme LLC · Tests: MK-1045, Rituximab, Rituximab biosimilar, Bendamustine, Cyclophosphamide Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201Phase 296 sites📍 Little Rock📍 Duarte📍 La Jolla Alliance for Clinical Trials in Oncology · Tests: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Etoposide A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies. NCT06542250Phase 1, Phase 231 sites📍 La Jolla📍 Boston📍 Rochester AstraZeneca · Tests: AZD5492 Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant Volume NCT07528781n/a1 site📍 Badalona Germans Trias i Pujol Hospital · Tests: analysis of the performance of an artificial intelligenced based software for analysis of 3D tranesophageal echocardiog… PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) NCT07263490n/a6 sites📍 Copenhagen📍 Hellerup📍 Herlev Copenhagen University Hospital, Hvidovre Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults NCT06664229NA1 site📍 Seoul Sunmi Song · Tests: Fall and dementia prevention exercise Cognitive Screening Made Easy for PCPs - Administrative Supplement NCT06928298NA3 sites📍 Austin📍 Austin📍 San Antonio University of Texas at Austin · Tests: RACS app Evaluation of CO-OP for Adolescents With Mild Intellectual Disability NCT06691698NA2 sites📍 Kristianstad📍 Karlstad Örebro University, Sweden · Tests: The Cognitive Orientation to Daily Occupational Performance Approach
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy